Sign up
Log in
12 Health Care Stocks Moving In Monday's After-Market Session
Share
Listen to the news

Gainers

  • Indaptus Therapeutics (NASDAQ:INDP) shares increased by 26.2% to $2.65 during Monday's after-market session. The market value of their outstanding shares is at $414.4 million.
  • Barinthus Biotherapeutics (NASDAQ:BRNS) stock increased by 12.46% to $0.73. The company's market cap stands at $26.6 million.
  • Regentis Biomaterials (AMEX:RGNT) shares increased by 10.93% to $1.42. The market value of their outstanding shares is at $6.8 million.
  • Structure Therapeutics (NASDAQ:GPCR) shares rose 8.95% to $41.15. The market value of their outstanding shares is at $2.6 billion.
  • QTREX Quantum (NASDAQ:QTEX) shares increased by 7.09% to $1.51. The market value of their outstanding shares is at $61.8 million.
  • XTL Biopharmaceuticals (NASDAQ:XTLB) shares moved upwards by 6.76% to $2.38. The company's market cap stands at $4.8 million.

Losers

  • iTonic Holdings (NASDAQ:ITOC) shares fell 38.9% to $0.31 during Monday's after-market session. The market value of their outstanding shares is at $4.7 million.
  • MetaVia (NASDAQ:MTVA) stock fell 11.72% to $1.96. The company's market cap stands at $13.2 million.
  • Basel Medical Group (NASDAQ:BMGL) stock decreased by 8.79% to $0.56. The company's market cap stands at $10.2 million.
  • Precision Optics Corp (NASDAQ:POCI) shares declined by 8.72% to $5.13. The market value of their outstanding shares is at $63.4 million.
  • IDEAYA Biosciences (NASDAQ:IDYA) stock fell 7.88% to $29.0. The company's market cap stands at $2.4 billion.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) stock fell 7.05% to $0.45. The company's market cap stands at $2.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.